Urania Therapeutics is developing a SBDD platform for the generation.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Strasbourg
State: Alsace
Zip:
Country: France
Urania Therapeutics company is developing a unique SBDD platform for the generation of new readthrough compounds with high potential in cancer and monogenic disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Seed Round | 1 | $1.9M |
Bpifrance Bpifrance |
11/2019 | Seed Round | $0 |
AdBio partners Cap Innov&s;Est AdBio partners Cap Innov&s;Est |
11/2019 | Seed Round | 2 | $3.9M |
AdBio partners Cap Innov&s;Est AdBio partners Cap Innov&s;Est |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|